# LESCOD: "Lewy Body Screening in Cognitive Disorders"

> **NCT02263287** · NA · TERMINATED · sponsor: **Nantes University Hospital** · enrollment: 133 (actual)

## Conditions studied

- Alzheimer Disease
- Lewy Body Disease

## Interventions

- **OTHER:** LeSCoD scale

## Key facts

- **NCT ID:** NCT02263287
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 133 (ACTUAL)
- **Why stopped:** recruitment problems
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02263287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02263287, "LESCOD: "Lewy Body Screening in Cognitive Disorders"". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02263287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*